These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 33633741)

  • 1. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Zhang B; Liu J; Mo Y; Zhang K; Huang B; Shang D
    Front Immunol; 2024; 15():1476904. PubMed ID: 39372416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
    Cheng H; Ma K; Zhang L; Li G
    Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
    He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
    Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of CD8
    Zhu Q; Yang Y; Zeng Y; Chen K; Zhang Q; Wang L; Huang Y; Jian S
    Int Immunopharmacol; 2024 Aug; 137():112447. PubMed ID: 38909497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOX-expressing terminally exhausted tumor-infiltrating CD8
    Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
    Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem-like CD8
    Steiner C; Denlinger N; Huang X; Yang Y
    Front Immunol; 2024; 15():1426418. PubMed ID: 39211052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
    Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
    J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to reinvigorate exhausted CD8
    Guan Q; Han M; Guo Q; Yan F; Wang M; Ning Q; Xi D
    Front Immunol; 2023; 14():1204363. PubMed ID: 37398660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Hypoxia-ALCAM
    Xun Z; Zhou H; Shen M; Liu Y; Sun C; Du Y; Jiang Z; Yang L; Zhang Q; Lin C; Hu Q; Ye Y; Han L
    Adv Sci (Weinh); 2024 Sep; 11(33):e2309885. PubMed ID: 38956900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.
    Zhang L; Zhang B; Li L; Ye Y; Wu Y; Yuan Q; Xu W; Wen X; Guo X; Nian S
    J Cancer Res Clin Oncol; 2023 May; 149(5):2243-2258. PubMed ID: 36107246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells.
    Fang Z; Ding X; Huang H; Jiang H; Jiang J; Zheng X
    Cancer Biol Med; 2024 May; 21(6):499-512. PubMed ID: 38825813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of transforming growth factor-β (TGF-β) in the formation of exhausted CD8 + T cells.
    Ma R; Sun JH; Wang YY
    Clin Exp Med; 2024 Jun; 24(1):128. PubMed ID: 38884843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and Molecular Mechanisms of CD8
    Verdon DJ; Mulazzani M; Jenkins MR
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Wang Q; Qin Y; Li B
    Cancer Lett; 2023 Apr; 559():216043. PubMed ID: 36584935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review).
    Luan J; Liu Y; Cao M; Guo X; Guo N
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38904200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunometabolism of CD8
    Shi H; Chen S; Chi H
    Trends Cancer; 2024 Jul; 10(7):610-626. PubMed ID: 38693002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic CD8
    Iwahori K
    Adv Exp Med Biol; 2020; 1224():53-62. PubMed ID: 32036604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.